expel-panc: bxcl701 and pembrolizumab in metastatic pancreatic ductal adenocarcinoma
Published 1 month ago • 54 plays • Length 0:54Download video MP4
Download video MP3
Similar videos
-
3:36
early findings show potential efficacy, safety of bxcl701, pembrolizumab for metastatic pdac
-
1:24
enhancing the efficacy of immunotherapies in pancreatic cancer with bxcl701
-
1:12
supporting ngs for pancreatic ductal adenocarcinoma
-
1:16
entinostat with nivolumab in pancreatic ductal adenocarcinoma
-
0:54
napoli-3: first-line nalirifox in metastatic pancreatic ductal adenocarcinoma
-
0:36
advances in the treatment of pancreatic cancer
-
1:26
immune checkpoint inhibition for pancreatic ductal adenocarcinoma a systematic review
-
2:53
cancer-foxp3 identifies pancreatic ductal adenocarcinoma patients for immunotherapy
-
2:34
bruin study update: analysis of the mechanisms of resistance to pirtobrutinib in cll
-
1:05
final analysis of the alpine trial: zanubrutinib vs ibrutinib in r/r cll
-
1:12:13
approach to neoadjuvant treated pancreatic ductal adenocarcinoma - dr. wang
-
2:27
hnrnpab：a key molecule in early metastasis of pancreatic ductal adenocarcinomas
-
0:40
1l nalirifox in advanced or metastatic pdac
-
13:38
treatment of metastatic pancreatic ductal cancer
-
1:02
dr. hendifar on the halo-202 study in metastatic pancreatic ductal adenocarcinoma
-
0:58
dr. wang-gillam on results of a phase 1 study with defactinib in pancreatic ductal adenocarcinoma
-
9:10
locally advanced pancreas cancer: phase ii lapact trial
-
2:35
pancreas: ductal adenocarcinoma
-
4:01
cryoablation for pancreatic cancer